BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
52 results:

  • 1. Establishment of a predictive nomogram for differentiated thyroid cancer: an inpatient-based retrospective study.
    Du J; Li W; Zhao X; Shen C; Zhang X
    Endokrynol Pol; 2023; 74(6):. PubMed ID: 37994582
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (fubp1) are negative prognostic factors for pancreatic cancer patient survival.
    Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F
    Clin Exp Med; 2023 Dec; 23(8):5089-5100. PubMed ID: 37910256
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Image Quality and Lesion Detectability of Pancreatic Phase Thin-Slice Computed Tomography Images With a Deep Learning-Based Reconstruction Algorithm.
    Nakamoto A; Onishi H; Tsuboyama T; Fukui H; Ota T; Ogawa K; Yano K; Kiso K; Honda T; Tatsumi M; Tomiyama N
    J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):698-703. PubMed ID: 37707398
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic performance of CA125, HE4, ROMA, and CPH-I in identifying primary ovarian cancer.
    Luo HJ; Hu ZD; Cui M; Zhang XF; Tian WY; Ma CQ; Ren YN; Dong ZL
    J Obstet Gynaecol Res; 2023 Mar; 49(3):998-1006. PubMed ID: 36609691
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of deep learning image reconstruction in the prediction of resectability of pancreatic cancer: Diagnostic performance and reader confidence.
    Lyu P; Neely B; Solomon J; Rigiroli F; Ding Y; Schwartz FR; Thomsen B; Lowry C; Samei E; Marin D
    Eur J Radiol; 2021 Aug; 141():109825. PubMed ID: 34144309
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preparation and Performance of Chemotherapy Drug-Loaded Graphene Oxide-Based Nanosheets That Target Ovarian cancer Cells via Folate Receptor Mediation.
    Wang J; Han S; Zhang Z; Wang J; Zhang G
    J Biomed Nanotechnol; 2021 May; 17(5):960-970. PubMed ID: 34082881
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. fubp1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
    Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of ACR TI-RADS, Kwak TI-RADS, ATA guidelines and KTA/KSThR guidelines in combination with SWE in the diagnosis of thyroid nodules.
    Zhang WB; Xu W; Fu WJ; He BL; Liu H; Deng WF
    Clin Hemorheol Microcirc; 2021; 78(2):163-174. PubMed ID: 33579829
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
    Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
    PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.
    Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115943
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Utilization of virtual low-keV monoenergetic images generated using dual-layer spectral detector computed tomography for the assessment of peritoneal seeding from ovarian cancer.
    Kim TM; Kim SY; Cho JY; Kim SH; Moon MH
    Medicine (Baltimore); 2020 Jun; 99(23):e20444. PubMed ID: 32501991
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long non-coding RNA small nucleolar RNA host gene 6 aggravates pancreatic cancer through upregulation of far upstream element binding protein 1 by sponging microRNA-26a-5p.
    Zhang XX; Chen H; Li HY; Chen R; He L; Yang JL; Xiao LL; Chen JL
    Chin Med J (Engl); 2020 May; 133(10):1211-1220. PubMed ID: 32433053
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
    Brown TA; Byrd K; Vreeland TJ; Clifton GT; Jackson DO; Hale DF; Herbert GS; Myers JW; Greene JM; Berry JS; Martin J; Elkas JC; Conrads TP; Darcy KM; Hamilton CA; Maxwel GL; Peoples GE
    Cancer Med; 2019 Aug; 8(10):4678-4687. PubMed ID: 31274231
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1.
    Fan P; Ma J; Jin X
    Biochem Biophys Res Commun; 2018 Nov; 505(3):830-836. PubMed ID: 30301530
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase Ib trial of folate binding protein (fbp)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
    Vreeland TJ; Litton JK; Qiao N; Philips AV; Alatrash G; Hale DF; Jackson DO; Peace KM; Greene JM; Berry JS; Clifton GT; Peoples GE; Mittendorf EA
    Clin Immunol; 2018 Jul; 192():6-13. PubMed ID: 29574039
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.
    Jackson DO; Byrd K; Vreeland TJ; Hale DF; Herbert GS; Greene JM; Schneble EJ; Berry JS; Trappey AF; Clifton GT; Hardin MO; Martin J; Elkas JC; Conrads TP; Darcy KM; Hamilton CA; Maxwell GL; Peoples GE
    Oncotarget; 2017 Feb; 8(9):15912-15923. PubMed ID: 27852036
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.
    Pénzváltó Z; Lánczky A; Lénárt J; Meggyesházi N; Krenács T; Szoboszlai N; Denkert C; Pete I; Győrffy B
    BMC Cancer; 2014 Nov; 14():837. PubMed ID: 25408231
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Iterative reconstruction algorithms of computed tomography for the assessment of small pancreatic lesions: phantom study.
    Choi JW; Lee JM; Yoon JH; Baek JH; Han JK; Choi BI
    J Comput Assist Tomogr; 2013; 37(6):911-23. PubMed ID: 24270113
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.
    Kobayashi M; Wakabayashi H; Kojima H; Konishi T; Okuda K; Yoneyama H; Kayano D; Tobisaka M; Tsushima H; Onoguchi M; Kawai K; Kinuya S
    Hell J Nucl Med; 2013; 16(3):175-80. PubMed ID: 24137580
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.